8/5/2013

A study in the Journal of Clinical Endocrinology & Metabolism revealed a 50% decline in beta-cell function in patients with impaired fasting glucose/impaired glucose tolerance as measured through acute insulin response, while those with normal glucose tolerance had a 31% decline as measured via a homeostasis model assessment of beta-cell function. Type 2 diabetes patients also showed a 70% decline in beta-cell function using HOMA B and an 80% decline as measured through acute insulin response, researchers said.

Related Summaries